HealthcareAug 10, 2026

GenScript

Company Profile Analysis

Book Demo Subscribe Now

Year Founded & Workforce

2001-12-31

5,573 Employees

Industry

Healthcare

Services

GenScript Overview

Company Headquarters: New Jersey, US

Founded: 2002

Workforce: ~5,573

Company Working:GenScript is a biotechnology company that provides solutions for life science applications and research. The company offers services in peptide synthesis, genome editing, cell engineering, mutation and library solutions, preclinical drug development, biologics, and manufacturing. The use of GenScript products is advantageous in the life sciences, vaccine research, immunotherapy, COVID-19 treatment, and new drug development. The company also uses its distinct gene synthesis technique in a number of different industries, such as cell therapies, commercial synthetic materials, translational biomedical development, and life science research. It operates in China, Singapore, Japan, the Netherlands, the UK, and the US.

Strategy

GenScript’ s mission is to offer clients high-quality goods and services, provide career and professional development opportunities for our staff, and generate long-term social value. It is focused on creating top-notch biotech platforms for research and development in synthetic biology and healthcare to support life science research, create ground-breaking technologies, deal with environmental problems, and treat serious illnesses for the benefit of humanity. Additionally, it also focuses on mergers and acquisitions which can give them a good rank among the competitors.

Company Snapshot

$273.4M

Revenue

5,573

Employees

2001-12-31

Founded

New Jersey, US

Headquarters

SWOT Analysis

Strengths

Strong distribution network across the globe
Highly invested in research and development activity as well as the production facility
Highly skilled workforce
Strong track record of project management in the biotechnology & drugs industry
Strong global presence in 100 countries
High brand equity
Successful track record of launching new products

Weaknesses

Highly depended on the US market for revenue generation
Limited revenue generated from industrial synthetic biology products segment
Low market penetration in new markets
High dependence on existing supply chain

Opportunities

Collaboration with public sector institutions
Growing research and development activity
Expansion in small and mid-sized business markets
Increase in government spending

Threats

Change in raw material cost
Availability of counterfeit products
Fluctuations in foreign exchange rates
Technology disruption because of hacks, piracy etc
Increasing international competition and downward pressure on margins

Key Developments

Date	Approach	Development
November 2021	Product Launch	GenScript has launched the GenWand Double-Stranded DNA (dsDNA) service for the manufacture of CRISPR knock-in homology-directed repair (HDR) templates in T-cell engineering.
April 2019	Product Launch	GenScript Launched a Single-stranded DNA Service for CRISPR-based gene editing. The newly launched service provides researchers with high-quality, pure ssDNA for CRISPR-based gene insertion, with the goal of accelerating the development of gene therapy, cell therapy, and transgenic animal models for cancer research and treatment.

Product Offering

GenScript
- Nanobody
- Gene Editing

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles GenScript as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

GenScript

Company Headquarters: New Jersey, US Founded: 2002 Workforce: ~5,573 Company Working:GenScript is a biotechnology company that provides solutions for life science applications and research. The company offers services in peptide synthesis, genome editing, cell engineering, mutation and library solutions, preclinical drug development, biologics, and manufacturing. The use of GenScript products is advantageous in the life sciences, vaccine research, immunotherapy, COVID-19 treatment, and new drug development. The company also uses its distinct gene synthesis technique in a number of different industries, such as cell therapies, commercial synthetic materials, translational biomedical development, and life science research. It operates in China, Singapore, Japan, the Netherlands, the UK, and the US.

Starting from

$4,950